Table 3.
Distribution of 2009–2013 mCRPC commercial claims and EMR cohorts based on age at time of first mCRPC drug usage
| 2009–2013 mCRPC Cohort | ||
|---|---|---|
| Commercial claimsn = 2138a | EMRn = 1340 | |
| Age, years | ||
| Median (interquartile range) | 70.0 (62–78) | 74.0 (67–80) |
| Age group, n (%) | ||
| 44–64 years | 759 (35.5) | 233 (17.4) |
| 65–80 years | 971 (45.4) | 776 (57.9) |
| >80 years | 402 (18.8) | 331 (24.7) |
EMR, electronic medical record; mCRPC, metastatic castration‐resistant prostate cancer.
a
14 patients were not included in the age group splits due to inconsistency or missing values in their date‐of‐birth data.